Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer

Diseases of the Colon and Rectum

Volumn 55, Issue 6, 2012, Pages 677-685

  Chen, Zhenbin ^a   Liu, Zheng ^b   Deng, Xutao ^b   Warden, Charles ^b   Li, Wenyan ^a   Garcia Aguilar, Julio ^a  

^a City of Hope ^*  (United States)

^b Bioinformatics Core   (United States)

Author keywords

Array based comparative genomic hybridization; Copy number alteration; Lymph node metastasis; Rectal cancer

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; CHROMOSOME 4; CHROMOSOME LOSS; COPY NUMBER VARIATION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PREDICTIVE VALUE; RADIATION DOSE; RECTUM CANCER; SENSITIVITY AND SPECIFICITY;

BIOPSY; CHEMORADIOTHERAPY; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENES, NEOPLASM; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84863628365     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31824f873f     Document Type: Article

References (28)

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
2. Ciccocioppo A, Stephens JH, Hewett PJ, Rieger NA. Complete pathologic response after preoperative rectal cancer chemoradiotherapy. ANZ J Surg. 2009;79:481-484.
3. Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer:a pooled analysis of individual patient data. Lancet Oncol. 2010;11:835-844.
4. Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer:increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199-6206.
5. Hendren SK, O'Connor BI, Liu M, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg. 2005;242:212-223. (Pubitemid 41033438)
6. Evans J, Patel U, Brown G. Rectal cancer: primary staging and assessment after chemoradiotherapy. Semin Radiat Oncol. 2011;21:169-177.
7. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet. 2009;10:241-251.
8. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444-454. (Pubitemid 44809057)
9. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643-649. (Pubitemid 29003936)
10. Teixeira MR, Heim S. Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences? Semin Cancer Biol. 2005;15:3-12. (Pubitemid 40018523)
11. Grade M, Gaedcke J, Wangsa D, et al. Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy. Cancer Genet Cytogenet. 2009;193:19-28.
12. Postma C, Koopman M, Buffart TE, et al. DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. Ann Oncol. 2009;20:1048-1056.
13. Cardoso J, Boer J, Morreau H, Fodde R. Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta. 2007;1775:103-137. (Pubitemid 44881195)
14. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC, Lothe RA. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer. 2006;45, 31-41. (Pubitemid 46930859)
15. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM; Timing of Rectal Cancer Response to Chemoradiation Consortium. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg. 2011;254:97-102.
16. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. Chicago, IL: Springer, Inc; 2010.
17. Chen Z, Liu Z, Li W, et al. Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer. Genes Chromosomes Cancer. 2011;50:689-699.
18. Benjamini YH, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995;57:289-300.
19. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003;100:9440-9445. (Pubitemid 37033947)
20. Shi L, Reid LH, Jones WD, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006;24:1151-1161. (Pubitemid 44359727)
21. Deng X, Campagne F. Introduction to the development and validation of predictive biomarker models from high-throughput data sets. Methods Mol Biol. 2010;620:435-470.
22. Bang H, Davidian M. Experimental statistics for biological sciences. Methods Mol Biol. 2010;620:3-104.
23. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics. 2005;21:3940-3941. (Pubitemid 41535515)
24. Ghadimi BM, Grade M, Liersch T, et al. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. Clin Cancer Res. 2003;9:1808-1814. (Pubitemid 36554608)
25. Diep CB, Teixeira MR, Thorstensen L, et al. Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients. Mol Cancer. 2004;23:3-6.
26. Arribas R, Ribas M, Risques RA, et al. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. Clin Cancer Res. 1999;5:3454-3459.
27. Bardi G, Fenger C, Johansson B, Mitelman F, Heim S. Tumor karyotype predicts clinical outcome in colorectal cancer patients. J Clin Oncol. 2004;22:2623-2634. (Pubitemid 41103750)
28. Chen Z, Duldulao MP, Li W, Lee W, Kim J, Garcia-Aguilar J. Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer. J Am Coll Surg. 2011;212:1008-1017.e1.